Grifols (GIKLY) Non-Current Assets (2010 - 2025)

Grifols (GIKLY) reported Non-Current Assets of $17.0 billion for Q4 2025, up 1.71% on a YoY basis from $16.8 billion in Q4 2024, and up 1.71% quarter-over-quarter from $16.8 billion in Q4 2024.

Grifols (GIKLY) Non-Current Assets (2010 - 2025) Analysis & Trends

Grifols has reported Non-Current Assets for 16 years, with the latest figure at $17.0 billion in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 1.71% year-over-year to $17.0 billion; the trailing twelve-month figure through Dec 2025 stood at $17.0 billion (up 1.71% YoY), and the FY2025 full-year result was $17.0 billion, up 31454.2% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $17.0 billion, up from $16.8 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $17.0 billion in Q4 2025, with the low at $15.7 billion in Q4 2021.
  • Historically, Non-Current Assets has averaged $16.5 billion across 5 years, with a median of $16.8 billion in 2024.
  • Annual changes were most pronounced in 2021 — Non-Current Assets climbed 8.73% — and 2023, when it decreased 5.24%.
  • Grifols' Non-Current Assets stood at $15.7 billion in 2021, then increased by 7.48% to $16.9 billion in 2022, then fell by 5.24% to $16.0 billion in 2023, then advanced by 4.77% to $16.8 billion in 2024, then climbed by 1.71% to $17.0 billion in 2025.
  • The last three Non-Current Assets figures came in at $17.0 billion (Q4 2025), $16.8 billion (Q4 2024), and $16.0 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 60.81 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 61.74 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 141.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 102.93 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 125.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 61.03 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 165.18 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 59.27 Bn
10 Grifols - - - 17.04 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.04 Bn
Dec 31, 2024 16.75 Bn
Dec 31, 2023 15.99 Bn
Dec 31, 2022 16.87 Bn
Dec 31, 2021 15.70 Bn
Dec 31, 2020 14.44 Bn
Sep 30, 2020 14.02 Bn
Mar 31, 2020 13.50 Bn
Dec 31, 2019 11.27 Bn
Sep 30, 2019 11.55 Bn
Mar 31, 2019 11.25 Bn
Dec 31, 2018 10.27 Bn
Sep 30, 2018 10.18 Bn
Jun 30, 2018 10.13 Bn
Mar 31, 2018 9.72 Bn
Dec 31, 2017 9.39 Bn
Jun 30, 2017 9.09 Bn
Dec 31, 2016 7.57 Bn
Sep 30, 2016 7.38 Bn
Jun 30, 2016 7.48 Bn